Wednesday, 3rd December Clinical Oncology Society of Australia 2014 Annual Scientific Meeting

Facilitated by A/Prof Natasha Michael

Speakers include:
A/Prof Natasha Michael, Director of Palliative Medicine, Cabrini Health
A/Prof Clare O'Callaghan, Sr Research Associate, Cabrini Health
Ms Angela Baird, Clinical Nurse Coordinator, Cabrini Health

This symposium will draw from Phase 1 and Phase 2 research conducted at a metropolitan cancer centre. Using the vignette technique and mixed method research, it involved close to one hundred cancer patients and their caregivers to understand and develop a cancer specific ACP intervention. It will highlight the need for a patient and family-centered approach to ACP and include recommendations from involved participants on future models of implementation
Using experiential data, we will specifically discuss complexities related to the iterative process of decision making that evolves in cancer patients and the need for professionals working in cancer care to be attuned to the widely varied reactions they may encounter. We will also critically appraise the use of the vignette technique as a communication approach to facilitate difficult ACP conversations

This breakfast session is free for conference delegates, but it’s important to register because we will be providing breakfast! You can register by selecting this breakfast session in the 'add-ons' section of the registration portal. 

Facilitated by COSA ASM keynote speaker, Mary McCabe and Priscilla Gates

Since the Institute of Medicine published the seminal report, “From Cancer Patient to Cancer Survivor: Lost in Transition” in 2005, tremendous strides have been made in developing models of care with attention to the services needed by this growing population. Key to the development and implementation of these clinical care models is the profession of nursing. This session will include a presentation of the unique and important roles for nurses. The range of services - from psychosocial counseling services to comprehensive independent practices- that are being instituted by nurses will be discussed with attention to the variety of care settings across countries.  The session will include time to share and compare nursing roles in survivorship care between the United States and Australia.  

This breakfast session is free for conference delegates, but it’s important to register because we will be providing breakfast! You can register by selecting this breakfast session in the 'add-ons' section of the registration portal. 

Facilitated by PoCoG ECR members, Sheleigh Lawler, Danette Langbecker, Amanda Hutchinson

On behalf of Australia's Psycho-oncology Co-operative Early Career Research Group we would like to invite you to a special breakfast. Our vision for this event is to provide early career researchers working in psycho-oncology and related areas with an opportunity to have a highly interactive question and answer session with speakers who will address developing your research profile using social media, career progression and being competitive for grants and fellowships. Come prepared with your questions. As early career researchers we all face high levels of competition whether it be for securing employment, or gaining that first grant as chief investigator.

This breakfast session is free for conference delegates, but it’s important to register because PoCoG will be providing breakfast! You can register by selecting this breakfast session in the 'add-ons' section of the registration portal. 

VOYCE (YerVOY Clinical nEtwork) is a clinical network and educational program designed to support medical oncologists and nurses in the safe and appropriate use of YERVOY® (ipilimumab). The cornerstone of VOYCE is peer-to-peer connectivity, and components include peer advisors, case-studies, and preceptorships. This session will explain how VOYCE may benefit both medical oncologists and nurses in their management of patients with metastatic melanoma on YERVOY treatment. Exploring the important collaborative relationship between the medical oncologist and nurse, representative experienced speakers will present case-studies demonstrating their concerted approaches to managing patients on YERVOY treatment. Attendees will have the opportunity to participate in interactive case-studies to learn about the efficacy and safety considerations of YERVOY. Join the conversation with VOYCE at COSA ASM 2014!

This breakfast session is free for conference delegates, but it’s important to register because Bristol-Myers Squibb will be providing breakfast! You can register by selecting this breakfast session in the 'add-ons' section of the registration portal. 

• Lung Cancer Globally: Where are we? - Matthew Peters
• Targeted therapy for NSCLC 2015: second gen, third gen and beyond - Thomas Lynch
• Surgery for Lung Cancer 2014: CT Nodule Stratification and Management - Harvey Pass
• Radiotherapy for lung cancer: Getting personal - David Ball
• New perspectives on symptom management during treatment for advanced lung cancer - Thomas Jagoe

• Lung Cancer: Butt out or screen? - Ian Olver
• The WHO FCTC: An international tool for tobacco control - Mary Assunta
• Oncologist and Tobacco - Sumitra Thongprasert
• Quit smoking after cancer diagnosis - Freddy Sitas

• Physical and biological approaches to measuring the dose distribution in synchrotron microbeam radiation therapy - Jeffrey Crosbie
• Biological Response of Tumours and Normal Tissues to Synchrotron Microbeam Radiation Therapy (MRT) - Peter Rogers
• Tunable Nano-Shearing: Some New Ideas for Capturing CTCs and Rare Molecules from Blood - Matt Trau
• Can we improve clinical outcomes using stereotactic radiotherapy for oligometastatic disease? - Sasha Senthi
• Biomarker studies in lung cancer and mesothelioma - Harvey Pass

Chair: Natasha Michael

• Mucositis and its links to other toxicities in lung cancer - Dorothy Keefe
• Recent advances in the epidemiology, assessment and management of refractory breathlessness in lung cancer - Irene Higginson
• Exercise in the management of fatigue in lung cancer - Thomas Jagoe
• Cancer pain: closing the evidence-practice gap - Melanie R Lovell

Access to appropriate and timely psychosocial care can be challenging for many people diagnosed with cancer, particularly for those living in rural or regional locations1. There is growing interest in delivery of clinical services using internet enabled technology, particularly the delivery of psychological interventions online2. This symposium aims to explore the growing body of research investigating the feasibility, acceptability and efficacy of delivering online psychological interventions in the context of cancer care. This symposium will explore the challenges and benefits of delivering psychological interventions online through the presentation of five different online psychological interventions across different patient groups.

• My Road Ahead: Results from an RCT evaluating an Online Psychological Support Program for Men with Prostate Cancer - Addie Wootten
• e-TC: Development and pilot testing of a web-based intervention to reduce anxiety and depression in survivors of testicular cancer  - Louise Heiniger
• Developing an online psychological support intervention for partners of men with prostate cancer - Jo-Anne Abbott
• Finding My Way: Preliminary findings from a RCT evaluating an internet self-help program for cancer-related distress - Emma Kemp
• Improving reach and uptake of psychosexual support: introducing Rekindle, a web-based psychosexual resource for all cancer survivors and their partners - Catalina Lawsin

• Impact of chemotherapy partner on efficacy of targeted agents in metastatic colorectal cancer (mCRC): Systematic review and meta-analysis - David Chan
• An updated meta-analysis of taxanes for metastatic breast cancer: 10 years on - Matthew M.K. Chan
• Risk factors for hypocalcaemia in patients with cancer receiving denosumab - Richard De Boer
• Predictive value of Immunohistochemical 4 plus Clinical Treatment Score in determining risk of Loco Regional Recurrence in Early Breast Cancer. - Roopa Lakhanpal
• Retrospective comparison of rectal cancer treatment in China and Australia from 1995-2012 - Jia Jenny Liu
• Survival outcomes following adjuvant fluoropyrimidine-containing chemotherapy for resected early stage rectal adenocarcinoma - Rebecca Y Tay

• “Not just following what doctors say”: piloting of a decision aid for women considering participation in the Sentinel Node Biopsy versus Axillary Clearance 2 (SNAC2) trial. - Alana Fisher
• Learning through clinical trials: 2013 and 2014 Preceptorship in Colorectal Cancer (CRC) - an initiative of the Australasian Gastro-Intestinal Trials Group (AGITG)  - Yada Kanjanapan
• Men’s and partners’ reactions to localised prostate cancer: Medical and community education on treatment options is needed - Clare O'Callaghan
• Potential interactions and issues associated with the use of CAM commonly used in the cancer population - Gail Rowan
• An innovative approach to online learning in adolescent and young adult (AYA) cancer care - Samantha A Van Staalduinen
• Are Indigenous cancer patients treated according to clinical guidelines? - Lisa J Whop

• Timely diagnosis of lung cancer - Jon Emery
• Functional imaging: Predicting patient outcomes during chemo-radiation therapy for NSCLC? - Sarah Everitt
• What factors influence patient outcomes: Early referral to palliative care - Julia Downing
• The inequity of being male; sex differences in prognostic outcomes for patients with cancer. - Zoe Wainer

• A review of the epidemiology, pathology, treatment and outcomes in  patients with Head and Neck cancer with focus on oropharyngeal squamous  cell carcinoma (OPSCC)  presented at Gold Coast University Hospital from 2011-2012 - Pawan Bajaj
• Genetic test declining and high cancer risk perception in DNA mismatch repair gene mutation families - Louisa Flander
• An International Survey of Awareness of Genetic Risk in the Adult and Paediatric Clinical Sarcoma Community - Kate McBride
• Outcomes of medical oncology patients admitted to ICU/HDU compared to non-cancer patients in a tertiary care centre - Mihitha H. Ariyapperuma
• Pharmacist advice on the safety of Complementary and Alternative Medicines (CAM) during conventional anticancer treatment - Arti Thakerar

• I-COPE: Pilot testing an innovative model of supportive and palliative care for patients with high grade glioma and their carers - Anna Collins
• Psychometric properties of an Australian Supportive Care Needs Assessment Tool for Indigenous People (SCNAT-IP) with cancer - Gail Garvey
• An audit and evaluation of the lung cancer journey: metropolitan and non-metropolitan - Barbara Page
• Patient and Clinician Perceptions of the Feasibility and Utility of Routine Unmet Needs Screening for Indigenous Australians with Cancer. - Belinda Thewes

• Quality of informed consent in clinical trials - Kim Adler
• RAINBOW: A global, phase 3, double-blind study of ramucirumab (RAM) plus paclitaxel (PTX) versus placebo (PL) + PTX in the treatment of advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma following disease progression on first-line platinum- and fluoropyrimidine-containing combination therapy: A subgroup analysis of Western population - Sumi Ananda
• Analysis of adjuvant chemotherapy in early stage Merkel Cell Carcinoma - Zia Ansari
• P16 Prevalence and incidence of recurrence in different subsites of oropharyngeal cancer: Retrospective analysis at single level institution from 2011-2012 - Pawan Bajaj
• Significant relationship between MTHFR C677T polymorphism and gastric cancer in Fars - Aboozar Barzegar
• Serum vitamin A, E, C and catalase in active and passive smokers in Nigeria - Iya Eze Bassey
• Genetic and epigenetic changes and their effect on prognosis and prediction of colorectal cancer - Arpad Bóday
• The impact of medical emergency team response on patterns of care at the end-of-life for people with incurable cancer - Christine Brown
• Assessment of time to commencement of neoadjuvant long course chemoradiotherapy (LCCRT) for locally advanced rectal adenocarcinoma patients in a tertiary referral hospital - Hayden Christie
• Assessment of long course chemoradiotherapy (LCCRT) in regards to completion of chemotherapy. The experience of a tertiary referral hospital - Hayden Christie
• Pathologic response of rectal adenocarcinoma to preoperative long course chemoradiotherapy (LCCRT). An assessment at a tertiary referral hospital - Hayden Christie
• Locally advanced and metastatic pancreatic cancer: An assessment of the provision of chemotherapy at a tertiary referral hospital - Hayden Christie
• Circulating tumour cells in early stage breast cancer The EMPathy Breast Cancer Network - Anthony Dowling
• Ipilimumab versus placebo after complete resection of stage III melanoma: efficacy and safety results from the EORTC 18071 phase III trial - Alexander M Eggermont
• Safety of combined exemestane and everolimus in postmenopausal hormone receptor positive metastatic breast cancer patients – a retrospective analysis - Jenny Gilchrist
• Merkel cell carcinoma: A case of palliative upper limb amputation in a patient with refractory in-transit metastases. - Dakshika A Gunaratne
• Comparison and Correlation of Vascular Endothelial Growth Factor (VEGF) Expression in Non Malignant Lesion, Premalignant Lesion and Squamous Cell Carcinoma (SCC) of Oral Cavity - Mayank Gupta
• Long-term survival of ipilimumab-naïve patients with advanced melanoma (MEL) treated with nivolumab (anti-Programmed Death-1; anti-PD-1; BMS-936558; ONO-4538) in a phase I trial. - Stephen Hodi
• Safety of treatment of liver carcinoma by percutaneous acetic acid injection: A preliminary report - Yuxin Hu
• Clinical significance of p53 and 4E molecular marker expression in head and neck squamous cell carcinoma of Northern Territory patients: An Australian retrospective study - Rama Dr Jayaraj
• Basic physical fitness testing protocol: What can it tell us about women touched by breast cancer? - John Keyserlingk
• Compliance with international guidelines and readability of informed consent forms for cancer clinical trials - James C Kuo
• Administration of chemotherapy in patients on dialysis - James Kuo
• Improving delivery of ambulatory care for cancer patients: experience of the Rapid Assessment Clinic in a tertiary institution - Madhawa De Silva
• Adjuvant chemotherapy in stage III colon cancer: A regional cancer care centre experience. - Andrew Lee
• Integration of scientists and clinical experts in Australia’s first molecular tumour board from the Victorian Comprehensive Cancer Centre (VCCC). - Belinda M Lee
• An initial analysis of preoperative serum microRNA-21 levels for the detection of ovarian carcinoma in patients with a pelvic mass - Wei Li
• Ki67 expression has prognostic significance in relation to human papillomavirus status in oropharyngeal squamous cell carcinoma - Jia Jenny Liu
• Plasma miR-320, miR-let-7e and miR-21 as novel potential biomarker for retinoblastoma detection - Qiuling Liu
• Evaluation of patient characteristics, clinical profile and treatment outcomes in glioblastoma multiforme: An institutional analysis - Robert Mason
• Nutrition screening and association with chemotherapy outcomes in older cancer patients - Alexandra McCarthy
• High-Risk Cutaneous Squamous Cell Carcinoma of Head and Neck with Parotid Metastasis: a review of 151 patients Treated at a Tertiary Referral Centre. - Lachlan McDowell
• Is bevacizumab in metastatic colorectal cancer effectiveness comparable to key Pharmaceutical Benefits Scheme submission clinical trials? Usage results from five large Queensland public hospitals - Daniel McKavanagh
• Intravenous versus oral flouropyramidine: Post gastrectomy chemoradiation - Hamza Mohammed
• Doctor-doctor communication of prognosis in metastatic cancer: a review of letters from medical oncologists to referring doctors - Erin B Moth
• Communication and information processing in patients with primary or metastatic brain malignancy – a survey of practice in two NSW metropolitan radiotherapy centres - Diana N Naehrig
• Cytokine receptor expression in acute myeloid leukemia: High expression of interleukin-2 receptor α-chain predicts a poor prognosis - Kazunori Nakase
• Four year outcomes after regional lymphadenectomy for stage III melanoma. - Prathyusha Nakka
• Response to chemotherapy in patients with gestational trophoblastic neoplasia and subsequent fertility - Muralidhar V Pai
• Comparison of clinical profile of oral cancers in young and elderly patients - A single institution series from South India - Ramya Rangarajan
• Fertility preservation toolkit: implementing & evaluating a resource to assist clinical discussion & decision making regarding fertility in paediatric oncology - Harene Ranjithakumaran
• Melanoma in the elderly, a different spectrum of disease? - Matthew J Rees
• Operable colorectal liver metastases: An Australian Institution Experience - Dhanusha Sabanathan
• ­Punching above the weight - high-dose methotrexate chemotherapy in extremes of body size - Geeta Sandhu
• Characteristics and Clinical Outcomes of Invasive Lobular Carcinoma of the Breast - Ayesha Saqib
• Impact of histopathological profile on 1.5-years disease progression of breast cancer patients: evidence from the Philippine DOH-Breast Cancer Medicine Access Program in medical oncology clinics of two tertiary hospitals - Marie Christine G. Semira
• Quality of life after cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy for peritoneal carcinomatosis: A systematic review and meta-analysis - Bernard L. Shan
• Gastrectomy for gastric carcinoma: A systematic review of quality of life - Bernard L. Shan
• Trans-arterial Embolisation Therapies for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review - Jocelyn Shan
• Assessment of surgical downstaging in an open-label Phase 2 trial of denosumab in patients with Giant Cell Tumour of Bone - Paul D Stalley
• Survival, response duration, and activity by BRAF mutation (MT) status of nivolumab (NIVO, anti-Programmed Death-1) and ipilimumab (IPI) concurrent therapy in advanced melanoma (MEL). - Mario Sznol
• Applying social-cognition models to understand women’s hypothetical intentions for Contralateral Prophylactic Mastectomy - Stephanie Tesson
• Single Institution Review of the Tolerability and Efficacy of Post Chemotherapy Abiraterone Acetate in a Regional Cancer Centre. - Padmini thanayankezhil
• Rapid fluorodeoxyglucose-positron emission tomography (FDG-PET) response to denosumab treatment in patients with giant cell tumour of bone (GCTB): results from two phase 2 trials - David Thomas
• Haematological Cancer Patients’ Views on Tissue Banking - Heidi Turon
• Implementing a protocol for vitamin-D screening and replacement in cancer patients - Wen Xu
• Training benefits of a Learning Management System (LMS) - Eliza Bott
• A randomised controlled trial of a couples-based sexuality intervention for men with localised prostate cancer who receive radical prostatectomy and their female partners - Suzanne K. Chambers
• Appetite for e-learning - educating clinicians on cancer malnutrition  - Lauren Muir
• Aflibercept in metastatic colorectal cancer (mCRC): Data from clinical trials, lessons from clinical practice - Siobhan Ng
• Development and implementation of the “Introduction to Oncology for Physiotherapists” study day - Sharni L Patchell
• Bridging the gap between city and country: A regional interdisciplinary educational workshop and DVD production in head and neck and upper gastrointestinal cancer management - Belinda Steer
• An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high? - Dane Cole-Clark
• Carcinoma tongue a retrospective review of treatment and outcome in 643 patients who had surgery as a primary modality of treatment - Nebu George
• Risk factors for metachronous colorectal neoplasia: a systematic review and meta-analysis - Harindra Jayasekara
• Posttraumatic stress disorder and posttraumatic growth in breast cancer patients - a logical analysis - Darshit Parikh
• A  study on cancer incidence in Nepal from 2003 -2010 - Kishore Preadhananga
• The Prevalence of Complementary and Alternative Medicine Use Among Patients With Malignancy at Royal Hobart HospitalLowenthal, R, Verma, N 2013 - Nidhi Verma
• Commencement of an allied health led, pre-radiation treatment group education session for head and neck cancer patients and carers - Jessica Abbott
• Learning Management System (LMS), the benefits of reporting - Eliza Bott
• Pazopanib toxicity monitoring - Elizabeth A. Connolly
• A different direction for social work in assisting those affected by mesothelioma - Olga Gountras
• Prostatectomy Clinic - Sonya Imbesi
• A retrospective study on rural oncology patient pathways - Talvika Kooblal
• The Evolution of a Multidisciplinary Cancer Cachexia Clinic - Peter Martin
• The Northern Health Outpatient Psycho-Oncology Service: Referral patterns and change in psychological distress over time.  - Hunter Mulcare
• The highs and lows of the MDT:  Experiences of working in a multidisciplinary team from the perspective of the Prostate Cancer Specialist Nurse in Tamworth, NSW. - Sharon L.E. Slack
• Outreach Clinic vs. Community Outreach: What’s in a name? A service provision review from the Prostate Cancer Specialist Nurse in Tamworth, NSW. - Sharon LE Slack
• A model of youth friendly genetic counselling - Kate Thompson
• Bloomhill Cancer Help: A unique community owned and operated cancer support service model. - Merran Z Williams
• Investigation of the total and Short Form Patient Generated Subjective Global Assessment (Short Form PG-SGA) score as a screening tool in chemotherapy outpatients - Jessica Abbott
• A phase III study of the impact of a physical activity program on disease-free survival in patients with high-risk stage II or stage III colon cancer: A randomized controlled trial (NCIC CTG CO.21) - Brandi Baylock
• The Colon Health And Life-Long Exercise ChaNgE (CHALLENGE) Trial: Participant adherence to fitness assessments - Brandi Baylock
• The support needs of terminally ill people living alone at home: A narrative review - Lauren J Breen
• Why do oncology outpatients who report emotional distress decline help? - Kerrie Clover
• Psychiatry registrars’ views and educational needs regarding the care of patients with life-limiting illnesses - Benjamin Forster
• Insomnia in cancer - Mathew George
• Predictors of high levels of distress and unmet needs in carers of High Grade Glioma patients over time - Georgia Halkett
• Patient, caregiver and healthcare professional’s experiences and perceptions of advance care planning in cancer patients: a systematic review - Stephanie Johnson
• Suitability of Cancer Registries for Recruiting Patients with Low-Incidence Cancers for Supportive Care Studies - Danette H Langbecker
• Supporting someone with cancer: the development and implementation of a carer support program at the Olivia Newton-John Cancer & Wellness Centre (ONJCWC). - Dianne Legge
• Havin’ A Yarn: A project to support Aboriginal people affected by cancer - Sue M Merritt
• The nurses’ role in monitoring patients with advanced melanoma receiving Ipilimumab in an ambulatory setting at Peter MacCallum cancer centre, Australia - Donna Milne
• The primacy of quality of life considerations: Meeting the client’s needs. Applying flexibility in the management of secondary lymphoedema in a palliative context - Ronna Moore
• The impact of an inpatient hospital admission on patient’s physical functioning and quality of life rate in the oncology setting. - Andrew Murnane
• Implementing a Leisure Activity Maintenance Program into an inpatient cancer setting - Jodie Nixon
• Scored Patient-Generated Subjective Global Assessment and serum albumin for nutritional assessment of gynecological cancer patients in palliative care - Camila S. Rodrigues
• Evaluating the utility of the QUAL-EC in the clinical care of patients with advanced cancer - Susan Slatyer
• What do patients understand about the information they receive during radiotherapy? - Haryana Dhillon
• Improving malnutrition screening in the radiotherapy setting - Belinda Steer
• Did the implementation of a prostate cancer specialist nursing service reduce unmet supportive care needs amongst carers? - Julie Sykes
• Musculoskeletal effects of exercise in men with prostate cancer initiating androgen deprivation therapy - Dennis R Taaffe
• Supporting Aboriginal and Torres Strait Islander people diagnosed with cancer to navigate the healthcare system - Laura Tam
• Gastrointestinal mucositis is associated with Muc 2 and 4 expression, and exocytosis of mucin stores - Daniel Thorpe
• An alternative Medical Services Advisory Committee (MSAC) assessment model: Inherited cancer as an exemplar. - Vanessa Tyrrell
• Factors associated with preference of communication about life expectancy with physicians among cancer patients under radiation therapy - Megumi Uchida
• Prevalence of fatigue among cancer patients under radiation therapy and its associated factors - Megumi Uchida
• Is crofelemer an effective intervention for dacomitinib-induced gastrointestinal toxicity?  - Ysabella Van Sebille
• "Undressing" distress among cancer patients and carers in regional Western Australia - Kaaren J Watts
• Item generation and content validity testing of the Health Literacy of Caregivers Scale-Cancer (HeLiCaS-C)  - Eva YN Yuen

Speakers:
- Medical oncologist - Sumitra Thongprasert
- Radiation oncologist - David Ball
- PET Physician - Sam Berlangieri
- Respiratory physician - Renee Manser
- Pathologist -Stephen Fox
- Surgeon - Harvey Pass
- Nurse - Mary Duffy
- Social worker - Elizabeth Dillon

This sessions follows a highly successful format used at previous meetings. It is designed to provide a forum for discussion of the complex issues which arise in the care of patients with lung cancer. The facilitator will present a series of challenging clinical cases and engage members of the multidisciplinary panel in discussion. There will also be opportunities for members of the audience to contribute to the discussion.

• Repressed microRNA expression in MPM: small genes, big impact - Glen Reid
• What’s new in malignant mesothelioma? - Stephen Clarke
• Malignant Pleural Effusion – Best Practice - Y C Gary Lee
• Mesothelioma from the patient's perspective: Quality of life and lived experience in people with MPM - Jason M Fowler

• Malnutrition in patients with lung cancer – results from the Victorian Cancer Services - Kathryn Marshall
• Science of cachexia - Thomas Jagoe
• Nutritional needs of people with mesothelioma - Judy Bauer
• Identifying risk factors for malnutrition in lung cancer patients receiving radiotherapy - Nicole Kiss
• What we have learnt in running a dedicated cancer cachexia service - Peter Martin

• Cannabis in cancer and palliative care - Donald Abrams
• Rational use of dietary supplements - Donald Abrams
• Health professional advice: COSA Position statement - Lesley Braun
• NHMRC Homeopathy Working Party - Nikolajs Zeps

• Impact of common genomic variants on melanoma risk prediction - Anne E. Cust
• Half of women with early breast cancer stop endocrine therapy before five years: Results from an Australian population-based study - Fran Boyle
• A population-based study of progression to metastatic prostate cancer in Australia - Qingwei Luo
• Risk estimates of lung cancer in a Chinese population at a later stage of the tobacco epidemic: Guangzhou Biobank Cohort Study - Tai Hing Lam
• Are Aboriginal people more likely to be diagnosed with advanced cancer?   - Dianne O'Connell
• A population-based study of breast cancer prevalence in Australia: predicting the future health care needs of women living with breast cancer - Xue Qin Yu

• Assessing the efficacy of ice-cream-formulated iron-saturated lactoferrin and anhydrous milk fat in preventing chemotherapy induced diarrhoea – the ReCharge Study, a randomised phase IIb trial - Sarah Benge
• Long-term outcomes of risk-reducing surgery in unaffected women at increased familial risk of breast and/or ovarian cancer - Louise Heiniger
• Radiation oncology outpatients’ concern about, preferences for, and perceived barriers to discussing anxiety and depression - Lisa Mackenzie
• Uptake and adherence to psychological support for cancer patients: A meta-regression - Rachel Brebach
• Addressing malnutrition in Victorian Cancer Services: Are we making a difference? - Kathryn Marshall
• Life expectancy discussions in a multi-site sample of Australian medical oncology outpatients - Rob Sanson-Fisher

Held in the Crown Palladium Room